Unknown OBSERVATIONAL NCT01519050

Predictors of Postoperative Left Ventricular Function in Patients Undergoing Mitral Valve Repair for Severe Degenerative Mitral Regurgitation

Sponsor: Edwards Lifesciences

Conditions Severe Degenerative Mitral Regurgitation

Updated 7 times since 2017 Last updated: Jan 25, 2012 Started: Nov 30, 2011 Primary completion: May 31, 2014 Completion: May 31, 2014

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This observational or N/A phase trial investigates Severe Degenerative Mitral Regurgitation and is currently ongoing. Edwards Lifesciences leads this study, which shows 7 recorded versions since 2011 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Unknown
Jul 2024 — Sep 2024 [monthly]

Unknown

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status
Jun 2018 — Jan 2021 [monthly]

Unknown Status
Apr 2018 — Jun 2018 [monthly]

Unknown Status

Phase: PHASE3 → None

▶ Show 2 earlier versions

Feb 2018 — Apr 2018 [monthly]

Unknown Status PHASE3
Jan 2017 — Feb 2018 [monthly]

Unknown Status PHASE3

First recorded

Nov 2011

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Edwards Lifesciences
University of Zurich

Data source: University of Zurich

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Zurich, Switzerland